Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from zidovudine + lamivudine to emtricitabine + tenofovir to prevent or reverse HIV-associated lipoatrophy
2005-005672-33Phase 4Completed
- Sponsor
- IATEC
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine, tenofovir disoproxil fumarate, zidovudine, lamivudine in Human immunodeficiency virus infection type 1, sponsored by IATEC. Started Mar 2006; status: completed.
02
Drugs
emtricitabinetenofovir disoproxil fumaratezidovudinelamivudine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2005-005672-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005672-33.